Among the clonality markers described in myeloid hematologic neoplasms or stem cell disorders that are associated with eosinophilia are tyrosine kinase gene rearrangements and JAK1, JAK2, and STAT5B mutations [24,25]. The gene discussed is STAT5B; the disease is Increased total eosinophil count.